Report Highlights

Healthcare Finance in the U.S.: Market Overview

The U.S. healthcare finance solutions market generated an estimated USD 48.6 billion in 2024, making it one of the largest consumer and provider credit niches in the country. Unlike markets where public systems fund most care, American patients absorb substantial out-of-pocket costs, which turns financing into a core access mechanism. Deductibles, coinsurance, and elective procedures excluded from insurance coverage drive demand for point-of-sale and installment credit. Providers also rely on revenue cycle financing to bridge the gap between claim submission and reimbursement.

Market structure departs sharply from global norms. Banks, card issuers, and specialty lenders dominate patient lending, while private equity-backed revenue cycle firms compete for provider receivables. Fragmentation across roughly 6,000 hospitals and hundreds of thousands of physician practices means no single buyer controls procurement. Distribution is therefore won practice by practice, through integrations with electronic health record and practice management platforms that determine which lenders reach the point of checkout.

Growth Drivers Behind U.S. Healthcare Finance

High-deductible health plans remain central to demand. Employer-sponsored and ACA marketplace plans push patients toward greater out-of-pocket liability, and KFF employer surveys show deductibles rising steadily across the 2020s. Patients facing these balances increasingly use installment and deferred-interest products to smooth payments, particularly for orthopedic, dental, and cardiac procedures where bills frequently exceed several thousand dollars.

Medicare Advantage enrollment, which exceeded 32 million beneficiaries in 2024 according to CMS, expands demand for provider cash flow solutions. Practices contracting with Medicare Advantage plans face delayed remittances and prior authorization friction, pushing them toward receivables financing. The aging population, with more Americans reaching 65 each year, reinforces this trend. Annual Medicare Physician Fee Schedule updates keep provider margins thin, which sustains reliance on external capital.

Restraints and Entry Barriers in U.S. Healthcare Finance

State lending licensure is the first barrier. Consumer installment lenders must obtain licenses under state small-loan and consumer finance statutes, and states such as New York and Illinois impose rate caps and disclosure rules that constrain pricing. Entrants also face the Truth in Lending Act and Regulation Z, which require standardized annual percentage rate disclosures in every patient financing contract. Multistate compliance therefore raises fixed costs substantially.

Incumbent advantage concentrates around the point-of-sale channel. Synchrony's CareCredit holds long-standing enrollment agreements with dental, veterinary, and aesthetic networks. Practice management vendors such as athenahealth and eClinicalWorks limit native financing integrations to established partners. Provider contracts also require HIPAA-compliant business associate agreements, which extend onboarding cycles by several months for new lenders.

Near-Term Opportunities in U.S. Healthcare Finance

Elective and cosmetic procedures represent the most accessible near-term opportunity. The American Society of Plastic Surgeons reported more than 1.5 million cosmetic surgical procedures in 2023, and most are self-pay. This yields an estimated USD 4.2 billion annual addressable pool for patient financing. Independent aesthetic practices in Florida, Texas, and California largely lack captive lending partners, creating a clear entry point for specialist lenders.

Revenue cycle financing for independent physician practices offers a second route. A majority of U.S. physicians now practice outside hospital-owned settings, which increases working capital pressure during Medicare Advantage reimbursement lags. An estimated USD 6.8 billion receivables financing pool exists among practices with fewer than 50 full-time equivalent employees. Lenders can source that pool through EHR-embedded partnerships that reduce customer acquisition costs.

Market at a Glance

Leading Market Participants

• Synchrony Financial
• CareCredit
• Prosper Healthcare Lending
• Optum Financial Services
• R1 RCM
• Waystar
• Experian Health
• Citizens Financial Group
• Wells Fargo
• Paymentus

Regulatory and Policy Environment for U.S. Healthcare Finance

The Consumer Financial Protection Bureau supervises larger nonbank consumer lenders under the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010. It enforces the Equal Credit Opportunity Act and the Fair Debt Collection Practices Act against lenders and collectors handling medical balances. The Health Insurance Portability and Accountability Act governs patient data, and the Office for Civil Rights enforces business associate agreements. Lenders integrating with provider systems must complete these compliance steps before go-live.

The No Surprises Act, effective January 1, 2022, establishes an independent dispute resolution process administered jointly by the Departments of Health and Human Services, Labor, and the Treasury. CMS price transparency rules require hospitals to publish standard charges, improving patient cost visibility for financing decisions. State regulators, including the New York Department of Financial Services, license consumer lenders and set rate ceilings. No federal subsidy supports consumer healthcare lending directly.

Long-Term Outlook for U.S. Healthcare Finance

By 2032, the market is projected to reach USD 84.3 billion, growing at 7.2 percent annually from the 2025 base year. Growth will shift from point-of-sale credit toward embedded provider lending as EHR vendors and payment platforms bundle financing into billing workflows. Orthopedics, fertility, and aesthetic specialties will become larger borrowers as cost transparency rises and procedure volumes expand across the South and West.

Regulatory pressure will narrow margins for lenders relying on high-rate installment products, particularly in states with strict usury caps. Entrants securing multistate licenses and HIPAA-compliant data architecture will capture consolidation opportunities as smaller regional lenders exit. Medicare Advantage growth and an aging population will sustain demand throughout the forecast period, rewarding providers and lenders that manage reimbursement timing effectively.